Rallybio Corp (RLYB): who owns it and who trades it
As of Nov 16, 2026, RLYB insiders reported 2 open-market sales worth $13.6K and 14 purchases worth $4.2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jonathan I Lieber (CFO), with $13.6K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Rallybio
From the latest filingsOverall: about as much buying as selling. Famous investors mostly sold. Insiders mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns RLYB
36 funds and institutions reported RLYB shares worth $66.9M at the end of Q2 2026, about 79% of the company. The largest holder is ADAR1 Capital Management, LLC with 17.5%.
Funds and institutions (13F) 79%Everyone else 21%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 926,352 | 17.51% | $14.8M | +4411% |
| FMR LLC (Fidelity) | 794,720 | 15.02% | $12.7M | +0% |
| Viking Global Investors LP | 524,347 | 9.91% | $8.4M | No change |
| Tpg Gp A, LLC | 378,551 | 7.16% | $6.1M | No change |
| Nantahala Capital Management, LLC | 376,844 | 7.12% | $6M | +25% |
| Pivotal bioVenture Partners Investment Advisor LLC | 300,579 | 5.68% | $4.8M | No change |
| Renaissance Technologies LLC | 199,907 | 3.78% | $3.2M | +28% |
| Vanguard Capital Management LLC | 172,497 | 3.26% | $2.8M | +54% |
| Almitas Capital LLC | 120,682 | 2.28% | $1.9M | -37% |
| Rangeley Capital, LLC | 104,850 | 1.98% | $1.7M | +248% |
| Mariner, LLC | 50,566 | 0.96% | $809K | No change |
| Jane Street Group, LLC | 47,423 | 0.90% | $759K | New |
| Geode Capital Management, LLC | 32,047 | 0.61% | $513K | -10% |
| BlackRock, Inc. | 30,332 | 0.57% | $485K | +73% |
| Hrt Financial LP | 25,657 | 0.49% | $410K | New |
| XTX Topco Ltd | 21,497 | 0.41% | $344K | +91% |
| Vanguard Fiduciary Trust Co | 16,820 | 0.32% | $269K | +24% |
| Two Sigma Investments, LP | 16,619 | 0.31% | $266K | New |
| State Street Corp | 12,996 | 0.25% | $208K | New |
| Quadrature Capital Ltd | 12,995 | 0.25% | $208K | New |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, RLYB insiders reported $4.2M of open-market purchases and $13.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Jonathan I Lieber | CFO | Sale | 599 | $16.04 | $9.6K | Form 4 |
| May 19, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 10,000 | $13.98 | $140K | Form 4 |
| May 19, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 200 | $13.80 | $2.8K | Form 4 |
| May 18, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 6,009 | $13.98 | $84K | Form 4 |
| May 15, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 200 | $13.95 | $2.8K | Form 4 |
| May 15, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 100 | $13.80 | $1.4K | Form 4 |
| May 13, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 4,081 | $13.80 | $56.3K | Form 4 |
| May 13, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 75,178 | $14.00 | $1.1M | Form 4 |
| May 12, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 800 | $13.83 | $11.1K | Form 4 |
| May 11, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 25,000 | $14.00 | $350K | Form 4 |
| May 11, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 5,100 | $14.00 | $71.4K | Form 4 |
| May 11, 2026 | ADAR1 Capital Management, LLC +1 | 10% owner | Purchase | 19,900 | $14.00 | $279K | Form 4 |
| May 5, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 35,101 | $14.00 | $491K | Form 4 |
| May 4, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 3,900 | $13.90 | $54.2K | Form 4 |
| May 4, 2026 | Daniel Schneeberger +1 | 10% owner | Purchase | 116,904 | $13.97 | $1.6M | Form 4 |
| Feb 23, 2026 | Jonathan I Lieber | CFO | Sale | 789 | $5.06 | $4K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Daniel Schneeberger | 10% owner | $3.3M | – | May 15, 2026 |
| ADAR1 Capital Management, LLC | 10% owner | $938K | – | May 19, 2026 |
| Jonathan I Lieber | Chief Financial Officer | – | $13.6K | Oct 27, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
RLYB short interest
Low short interest. 0.7% of RLYB shares are sold short: about 1 share in 138. Over the last 12 reports the number of shares short went down 93%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 39,026 RLYB shares were sold short, 0.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 33,171 shares, buying them all back would take about 1.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 39,026 | 0.72% | -5% | 33,171 | 1.2 |
| Oct 15, 2026 | 40,962 | 0.77% | -17% | 5,544 | 7.4 |
| Sep 30, 2026 | 49,245 | 0.93% | -11% | 10,095 | 4.9 |
| Sep 15, 2026 | 55,556 | 1.05% | +1% | 11,022 | 5.0 |
| Aug 31, 2026 | 54,943 | 1.03% | +1% | 9,996 | 5.5 |
| Aug 14, 2026 | 54,564 | 1.03% | -14% | 26,981 | 2.0 |
| Jul 31, 2026 | 63,485 | 1.20% | -63% | 30,844 | 2.1 |
| Jul 15, 2026 | 170,156 | 3.22% | -58% | 48,124 | 3.5 |
| Jun 30, 2026 | 408,746 | 7.73% | -4% | 47,572 | 8.6 |
| Jun 15, 2026 | 425,033 | 8.04% | -28% | 86,454 | 4.9 |
| May 29, 2026 | 586,906 | 11.10% | +1% | 48,977 | 12.0 |
| May 15, 2026 | 578,792 | 10.94% | -63% | 1.00M | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Rallybio company events
Rallybio filed 10 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership, control). The latest was on Nov 10, 2026.
- Nov 10, 2026AnnouncementRallybio Corporation announced that it will effect a one-for-two reverse stock split of its issued and outstanding common stock in connection with the transactions contemplated by the Agreement and Plan of Merger and Reorganization, dated as of May 31, 2026, among the Company, Avenzo Therapeutics… Filing
- Nov 6, 2026AnnouncementRallybio Corporation previously disclosed that, subject to the satisfaction or waiver of any outstanding closing conditions, the Company anticipated the transactions contemplated by the Agreement and Plan of Merger and Reorganization, dated as of May 31, 2026, by and among the Company, Avenzo… Filing
- Nov 4, 2026Leadership2026 Equity Incentive Plan At the annual meeting of the stockholders of Rallybio Corporation held on November 4, 2026, the Company’s stockholders considered and approved the Avenzo Therapeutics, Inc. 2026 Equity Incentive Plan, which will become effective on the date immediately following the… Filing
- Oct 26, 2026AnnouncementAs previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger and Reorganization with Avenzo Therapeutics, Inc., a Delaware corporation, and Farmington Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of… Filing
- Sep 9, 2026LeadershipRallybio Corporation (Rallybio) announced that Jonathan Lieber, Rallybio’s Chief Financial Officer, will transition to part-time employment status effective September 15, 2026 (the Employment Transition Date), but will remain Rallybio’s Chief Financial Officer and Principal Financial Officer and… Filing
- Jun 1, 2026ControlTo the extent required by this Item, the information included in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. Filing
- May 4, 2026AgreementEnded an important agreement. Filing
- Mar 31, 2026LeadershipRallybio Corporation (Rallybio) announced that Steven Ryder, M.D., who has served as Rallybio’s Chief Medical Officer since January 2019, will leave Rallybio effective immediately. Filing
- Mar 2, 2026ControlTo the extent required by this Item, the information included in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. Filing
- Jan 29, 2026VoteReported shareholder vote results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Rallybio financials
Famous investors that hold RLYB
3 of the 50 well-known investors we track reported holding RLYB in their latest 13F filing. The largest position is Andreas Halvorsen's, worth $9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Andreas Halvorsen · Viking Global Investors | Q3 2026 | 524,347 | $9M | 0.0% | No change |
| Jim Simons · Renaissance Technologies | Q3 2026 | 146,025 | $2.5M | 0.0% | -27% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 47,709 | $821K | 0.0% | -34% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Rallybio Corp (RLYB) stock
Who owns the most RLYB stock?
The largest reported owner of Rallybio Corp (RLYB) is ADAR1 Capital Management, LLC, with 17.5% of the company. In total, 36 funds and institutions reported holding RLYB at the end of Q2 2026, together about 79% of the shares. See the largest owners.
Are RLYB insiders buying or selling?
In the last 12 months, RLYB insiders reported 14 open-market purchases worth $4.2M and 2 sales worth $13.6K. The latest trade was on Oct 27, 2026. See every trade.
What is the short interest in RLYB?
As of Oct 30, 2026, 39,026 RLYB shares were sold short, 0.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 33,171 shares, buying them all back would take about 1.2 trading days (days to cover). See the history.
Which famous investors hold RLYB?
3 of the 50 well-known investors we track reported RLYB in their latest 13F filing, including Andreas Halvorsen, Jim Simons, Ken Griffin. The largest position is worth $9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.